Menstrual disorders, such as heavy menstrual bleeding (HMB), can be particularly challenging in women on anticoagulation therapy. Non-hormonal treatments like tranexamic acid may be considered, but their interaction with anticoagulants should be carefully evaluated. Hormonal therapies may be used judiciously, with a preference for options that minimize thromboembolic risk.
